Streetwise MLPs Sponsors
Select a name to see a detailed description, expert analysis and contact information.
|"DXD timeline to have a commercial product is much shorter than a traditional biotech company developing a new drug."|
|"GSV closed its equity financing; it raised an aggregate of $38.2M."|
|"VIT arranged a financing package worth up to as much as $505M."|
|"R entered into an agreement with Red Eagle Exploration."|
|"VIVE's Q4/17 revenue of $5.1M was up 108% year over year."|